BB&T Co. (NYSE:BBT) Shares Acquired by Family Legacy Inc.

Share on StockTwits

Family Legacy Inc. lifted its stake in shares of BB&T Co. (NYSE:BBT) by 9.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,724 shares of the insurance provider’s stock after acquiring an additional 685 shares during the period. Family Legacy Inc.’s holdings in BB&T were worth $379,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Mn Services Vermogensbeheer B.V. lifted its position in BB&T by 196.2% during the second quarter. Mn Services Vermogensbeheer B.V. now owns 392,543 shares of the insurance provider’s stock worth $19,286,000 after buying an additional 260,000 shares during the period. D. Scott Neal Inc. lifted its position in BB&T by 17.6% during the second quarter. D. Scott Neal Inc. now owns 7,832 shares of the insurance provider’s stock worth $385,000 after buying an additional 1,170 shares during the period. RNC Capital Management LLC lifted its position in BB&T by 974.4% during the second quarter. RNC Capital Management LLC now owns 587,050 shares of the insurance provider’s stock worth $28,842,000 after buying an additional 532,410 shares during the period. Mitchell Capital Management Co. lifted its position in BB&T by 25.8% during the second quarter. Mitchell Capital Management Co. now owns 31,640 shares of the insurance provider’s stock worth $1,554,000 after buying an additional 6,480 shares during the period. Finally, Farmers & Merchants Investments Inc. lifted its position in BB&T by 5.1% during the second quarter. Farmers & Merchants Investments Inc. now owns 109,663 shares of the insurance provider’s stock worth $5,388,000 after buying an additional 5,326 shares during the period. 68.08% of the stock is currently owned by institutional investors and hedge funds.

Several equities analysts recently weighed in on BBT shares. ValuEngine upgraded BB&T from a “sell” rating to a “hold” rating in a research report on Wednesday, May 1st. Deutsche Bank set a $59.00 target price on BB&T and gave the stock a “buy” rating in a research report on Friday, July 26th. JPMorgan Chase & Co. reduced their target price on BB&T from $51.50 to $50.50 and set a “neutral” rating on the stock in a research report on Tuesday, July 9th. Morgan Stanley reduced their target price on BB&T from $56.00 to $53.00 and set an “equal weight” rating on the stock in a research report on Monday, April 22nd. Finally, UBS Group reduced their target price on BB&T from $55.00 to $53.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. Eight equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. BB&T currently has a consensus rating of “Hold” and a consensus price target of $54.04.

In other news, insider Donta L. Wilson sold 3,418 shares of BB&T stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $49.16, for a total value of $168,028.88. Following the completion of the transaction, the insider now owns 14,911 shares in the company, valued at approximately $733,024.76. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Louis B. Lynn sold 2,500 shares of BB&T stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $48.33, for a total value of $120,825.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 27,623 shares of company stock valued at $1,405,359. Insiders own 0.49% of the company’s stock.

BBT stock opened at $49.35 on Monday. The company has a current ratio of 0.88, a quick ratio of 0.87 and a debt-to-equity ratio of 0.79. BB&T Co. has a 1 year low of $40.68 and a 1 year high of $53.08. The firm has a market capitalization of $37.80 billion, a price-to-earnings ratio of 12.19, a P/E/G ratio of 1.25 and a beta of 1.12. The company has a 50-day moving average of $49.90.

BB&T (NYSE:BBT) last issued its quarterly earnings data on Thursday, July 18th. The insurance provider reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.04. BB&T had a return on equity of 12.23% and a net margin of 23.58%. The firm had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.01 billion. During the same quarter last year, the firm earned $1.01 EPS. BB&T’s quarterly revenue was up 5.7% on a year-over-year basis. As a group, research analysts expect that BB&T Co. will post 4.23 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 3rd. Stockholders of record on Wednesday, August 14th will be given a $0.45 dividend. The ex-dividend date of this dividend is Tuesday, August 13th. This represents a $1.80 annualized dividend and a dividend yield of 3.65%. BB&T’s payout ratio is 40.00%.

BB&T Company Profile

BB&T Corporation, a holding company, provides banking and trust services for small and mid-size businesses, public agencies, local governments, corporations, and individuals in the Southeastern and Mid-Atlantic United States. The company operates through four segments: Community Banking Retail and Consumer Finance, Community Banking Commercial, Insurance Holdings, and Financial Services and Commercial Finance.

Further Reading: Investing in Blue-Chip Stocks

Want to see what other hedge funds are holding BBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BB&T Co. (NYSE:BBT).

Institutional Ownership by Quarter for BB&T (NYSE:BBT)

Receive News & Ratings for BB&T Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BB&T and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SpartanNash  Lifted to “Hold” at Pivotal Research
SpartanNash Lifted to “Hold” at Pivotal Research
SpartanNash  Lifted to “Hold” at ValuEngine
SpartanNash Lifted to “Hold” at ValuEngine
ValuEngine Lowers Sportsman’s Warehouse  to Sell
ValuEngine Lowers Sportsman’s Warehouse to Sell
Sorrento Therapeutics  Raised to “Hold” at Zacks Investment Research
Sorrento Therapeutics Raised to “Hold” at Zacks Investment Research
Sierra Oncology  Upgraded at Zacks Investment Research
Sierra Oncology Upgraded at Zacks Investment Research
Zacks Investment Research Lowers Sierra Oncology  to Hold
Zacks Investment Research Lowers Sierra Oncology to Hold


© 2006-2019 Ticker Report